JP2025516298A5 - - Google Patents
Info
- Publication number
- JP2025516298A5 JP2025516298A5 JP2024564817A JP2024564817A JP2025516298A5 JP 2025516298 A5 JP2025516298 A5 JP 2025516298A5 JP 2024564817 A JP2024564817 A JP 2024564817A JP 2024564817 A JP2024564817 A JP 2024564817A JP 2025516298 A5 JP2025516298 A5 JP 2025516298A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- liquid pharmaceutical
- stable liquid
- formulation
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337532P | 2022-05-02 | 2022-05-02 | |
| US63/337,532 | 2022-05-02 | ||
| PCT/US2023/020660 WO2023215267A1 (en) | 2022-05-02 | 2023-05-02 | Anti-interleukin-4 receptor (il-4r) antibody formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516298A JP2025516298A (ja) | 2025-05-27 |
| JP2025516298A5 true JP2025516298A5 (cg-RX-API-DMAC7.html) | 2026-05-12 |
Family
ID=86609834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564817A Pending JP2025516298A (ja) | 2022-05-02 | 2023-05-02 | 抗インターロイキン-4受容体(il-4r)抗体製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240024472A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4518837A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025516298A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250004863A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119136787A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023263975A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3250514A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024014835A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316264A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024013496A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202406572A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215267A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025017034A1 (en) * | 2023-07-17 | 2025-01-23 | Formycon Ag | Stable liquid antibody formulation for dupilumab |
| WO2025116637A1 (ko) * | 2023-12-01 | 2025-06-05 | 삼성바이오에피스 주식회사 | 항-IL-4Rα 항체의 안정한 액상 제형 |
| EP4623903A1 (en) * | 2024-03-28 | 2025-10-01 | Fresenius Kabi Deutschland GmbH | Pharmaceutical composition comprising dupilumab |
| KR20260105275A (ko) * | 2024-12-26 | 2026-07-06 | 주식회사 종근당 | 항-hIL-4Rα 항체를 위한 안정화된 액상 조성물 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| PT2990420T (pt) | 2000-05-26 | 2017-03-16 | Immunex Corp | Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| UA93653C2 (ru) | 2003-11-07 | 2011-03-10 | Иммунекс Корпорейшн | Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r) |
| CA2664343C (en) | 2006-10-02 | 2016-04-26 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| MX366337B (es) * | 2010-10-06 | 2019-07-05 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r). |
| JP5859148B2 (ja) * | 2012-03-08 | 2016-02-10 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Aβ抗体製剤 |
| EP2823841A1 (en) | 2013-07-09 | 2015-01-14 | Sanofi-Aventis Deutschland GmbH | Autoinjector |
| RU2689145C2 (ru) * | 2014-04-16 | 2019-05-24 | Биокон Лтд. | Стабильные белковые препараты, содержащие молярный избыток сорбитола |
| AR102198A1 (es) | 2014-10-09 | 2017-02-08 | Regeneron Pharma | Proceso para reducir partículas subvisibles en una formulación farmacéutica |
| TW201707738A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 注射器支架及自動注射器(二) |
| TW201711716A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 護罩鎖 |
| TW201709941A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器(二) |
| TW201711713A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置(五) |
| TW201707741A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 針頭護罩之抓握器、蓋子、自動注射器及製造抓握器之方法 |
| CN107474134B (zh) | 2016-06-08 | 2021-07-27 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| CN110540590B (zh) | 2018-05-29 | 2023-08-18 | 康诺亚生物医药科技(成都)有限公司 | 一种自免疫抑制物的开发和应用 |
| MX2021001143A (es) | 2018-08-24 | 2021-04-12 | Jiangsu Hengrui Medicine Co | Anticuerpo de union a il-4r humana, fragmento de union a antigeno y uso medico del mismo. |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN111494626B (zh) | 2018-12-25 | 2022-06-21 | 江苏荃信生物医药股份有限公司 | 用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物 |
| SG11202107007VA (en) | 2018-12-27 | 2021-07-29 | Akeso Biopharma Inc | Antibody against human il-4ra and use thereof |
| CN111592597B (zh) | 2019-05-29 | 2022-04-26 | 山东博安生物技术股份有限公司 | 白介素4受体(il-4r)结合蛋白及其用途 |
-
2023
- 2023-05-02 EP EP23727738.9A patent/EP4518837A1/en active Pending
- 2023-05-02 IL IL316264A patent/IL316264A/en unknown
- 2023-05-02 US US18/142,196 patent/US20240024472A1/en active Pending
- 2023-05-02 AU AU2023263975A patent/AU2023263975A1/en active Pending
- 2023-05-02 JP JP2024564817A patent/JP2025516298A/ja active Pending
- 2023-05-02 TW TW112116324A patent/TW202406572A/zh unknown
- 2023-05-02 WO PCT/US2023/020660 patent/WO2023215267A1/en not_active Ceased
- 2023-05-02 CN CN202380038045.5A patent/CN119136787A/zh active Pending
- 2023-05-02 KR KR1020247039194A patent/KR20250004863A/ko active Pending
- 2023-05-02 CA CA3250514A patent/CA3250514A1/en active Pending
-
2024
- 2024-10-30 CO CONC2024/0014835A patent/CO2024014835A2/es unknown
- 2024-10-31 MX MX2024013496A patent/MX2024013496A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6456470B2 (ja) | 抗pcsk9抗体を含む安定化製剤 | |
| KR102667484B1 (ko) | 안정한 항체 제형 | |
| JP6396565B2 (ja) | 抗インターロイキン−4受容体(il−4r)抗体を含有する安定化製剤 | |
| US12559551B2 (en) | Stabilized formulations containing anti-ANGPTL3 antibodies | |
| CN102458469B (zh) | 人抗TNF-α抗体的稳定高蛋白质浓度制剂 | |
| JP2016020371A (ja) | 抗インターロイキン6受容体(il−6r)抗体を含有する安定化製剤 | |
| JP2022526292A5 (cg-RX-API-DMAC7.html) | ||
| US20220202937A1 (en) | Novel Formulations Which Stabilize Low Dose Antibody Compositions | |
| JP2023511080A (ja) | 安定な抗体製剤 | |
| AU2024372916A1 (en) | Stable antibody formulation comprising fianlimab | |
| TWI498121B (zh) | 含有抗-介白素-4受體(il-4r)抗體之安定化配製物 | |
| JP2023533963A5 (cg-RX-API-DMAC7.html) | ||
| RU2024135750A (ru) | Составы антитела к рецептору интерлейкина-4 (il-4r) | |
| CN115812080A (zh) | 含有抗ctla-4抗体的稳定调配物 | |
| CN121360224A (zh) | 一种抗tslp抗体药物组合物及其用途 | |
| EA047546B1 (ru) | Стабилизированные составы, содержащие антитела анти-pcsk9 |